Specialties:

Most Popular Reports:

Newest Reports:

Discussion Varicose Vein-Current and Emerging Therapies_JUL2006
July 2006
Deliverable: Transcripts Only

Objectives:

  • Understand the current varicose vein treatment market landscape
  • Compare laser therapy with radiofrequency ablation and vein stripping
  • Evaluate the potential market share expansion of endovenous laser treatment generally and of Diomed’s EVLT® specifically
  • Determine how Diomed’s EVLT compares with other laser therapies (i.e., AngioDynamics’ VenaCure™, Vascular Solutions’ Vari-Lase, CoolTouch’s CTEV™)

Products Highlighted:

  • EVLT (Diomed)
  • VenaCure (AngioDynamics)
  • Vari-Lase (Vascular Solutions)
  • CTEV (CoolTouch)

Topics:

  • Current varicose vein treatment practices
  • Comparison of three techniques for treating varicose veins
  • Perception and use of laser therapy
  • Comparison of brands of laser therapy
  • Trends in treatment in the next 3-5 years

Quotes:

  • Probably one of the most important factors influencing which procedure to utilize is…
  • I believe EVLT and RF ablation have … results. I believe the RF catheters are …. I rarely perform … procedures since now performing ……
  • I am very familiar with … and … brands, and have heard of the other two…
  • I believe in 5 yrs, the majority of varicose vein patients will be treated with … especially if……

Screening Criteria:

  • Nine vascular surgeons and interventional radiologists
  • High-volume treaters of varicose veins; a mix of users of three alternatives: endovenous laser, radiofrequency (RF) ablation, and vein stripping
Representative Institutions:
  • Alegent Health
  • Baptist Hospital
  • Buffalo General Hospital
  • Cleveland Clinic Foundation
  • Emory University Hospital
  • General Vascular Surgery Medical Group
  • Parma Hospital/Private
  • Saints Memorial Medical Center
  • Washington Hospital Center
Download this report

 

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy